Allianz Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Allianz Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38,895	Closed	-$1.83M	–	2230
2020 Q4	$1.83M	Buy	38,895 +18,985	+95%	+$748K	﹤0.01%	1342
2020 Q3	$936K	Hold	19,910	–	–	﹤0.01%	1445
2020 Q2	$596K	Buy	+19,910	New	+$412K	﹤0.01%	1997

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Allianz Asset Management's NBP Position: Q1 2021 in Review

Allianz Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2021, closing a stake of 38,895 shares — an estimated $1.83M sold.

Allianz Asset Management first reported a position in NBP in Q2 2020 and held it in 3 quarters. The position peaked at $1.83M in Q4 2020. 80 funds tracked by Wall St. Rank hold NBP as of Q1 2021.

Allianz Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Allianz Asset Management sold 38,895 NovaBridge Biosciences American Depositary Shares shares in Q1 2021, an estimated $1.83M.
Allianz Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and held it in 3 quarters.
Allianz Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $1.83M in Q4 2020.
80 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.